Manufacturer record

Spansules formulation India Pvt Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Spansules formulation India Pvt Ltd (Telangana) were declared Not of Standard Quality between December 2024 and December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

1 record linked to Spansules formulation India Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2024 to Dec 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2024
1
Products affected
Dissolution
Most common failure
Dec 2024
Latest alert

Flagged batches per year

2024 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Pantoprazole Sodium Tabletes IP 40mg P01824Mfg 2024-08 · Exp 2026-07 The sample Does not comply in respect of Dissolution Test as per IP.Dissolution State Lab Drugs Control Laboratory, TelanganaState lab Dec 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.